A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Cited by (1,095)

Items 301–400 of 1,095

1. Regulation of dopamine system responsivity and its adaptive and pathological response to stress
   Pauline Belujon, Anthony A. Grace · 2015 · Proceedings of the Royal Society B Biological Sciences
2. Pharmacological treatment of anxiety disorders: Current treatments and future directions
   Frank J. Farach, Larry D. Pruitt, Janie J. Jun, Alissa B. Jerud, Lori A. Zoellner, Peter Roy‐Byrne · 2012 · Journal of Anxiety Disorders
3. Differentiating antidepressants of the future: Efficacy and safety
   Sharon J. Rosenzweig-Lipson, Chad E. Beyer, Zoë A. Hughes, Xavier Z. Khawaja, S. Johannes R. Rajarao, Jessica E. Malberg, Zia Ur Rahman, Robert H. Ring, Lee E. Schechter · 2006 · Pharmacology & Therapeutics
4. Depression as a Glial-Based Synaptic Dysfunction
   Daniel Rial, Cristina Lemos, Helena Pinheiro, Joana Mendes Duarte, Francisco Q. Gonçalves, Joana I. Real, Rui Daniel Prediger, Nélio Gonçalves, Catarina A. Gomes, Paula M. Canas et al. · 2016 · Frontiers in Cellular Neuroscience
5. Identifying fast-onset antidepressants using rodent models
   Marcia J. Ramaker, Stephanie C. Dulawa · 2017 · Molecular Psychiatry
6. Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial
   Abbar, Mocrane, Demattei, Christophe, El-Hage, Wissam, Llorca, Pierre-Michel, Samalin, Ludovic, Demaricourt, Pierre, Gaillard, Raphael, Courtet, Philippe, Vaiva, Guillaume, Gorwood, Philip et al. · 2022 · BMJ
7. Mechanisms of Rapid Antidepressant Effects of Sleep Deprivation Therapy: Clock Genes and Circadian Rhythms
   Bunney, Blynn G., Bunney, William E. · 2013 · Biological Psychiatry
8. Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists
   Krystal, John H., Mathew, Sanjay J., DʼSouza, D. Cyril, Garakani, Amir, Gunduz-Bruce, Handan, Charney, Dennis S. · 2010 · CNS Drugs
9. Pharmacology of Sedative-Analgesic Agents: Dexmedetomidine, Remifentanil, Ketamine, Volatile Anesthetics, and the Role of Peripheral Mu Antagonists
   Oliver P. F. Panzer, Vivek K. Moitra, Robert N. Sladen · 2009 · Critical Care Clinics
10. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression
    Zheng, Wei, Zhou, Yan-Ling, Liu, Wei-Jian, Wang, Cheng-Yu, Zhan, Yan-Ni, Li, Han-Qiu, Chen, Li-Jian, Li, Ming Ding, Ning, Yu-Ping · 2018 · Journal of Psychiatric Research
11. Targeting Homeostatic Synaptic Plasticity for Treatment of Mood Disorders
    Kavalali, Ege T., Monteggia, Lisa M. · 2020 · Neuron
12. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial
    Ionescu, Dawn F., Bentley, Kate H., Eikermann, Matthias, Taylor, Norman, Akeju, Oluwaseun, Swee, Michaela B., Pavone, Kara J., Petrie, Samuel R., Dording, Christina, Mischoulon, David et al. · 2019 · Journal of Affective Disorders
13. Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression
    Zink, M., Vollmayr, B., Gebicke-Haerter, P.J., Henn, F.A. · 2010 · Neuropharmacology
14. Riluzole in the Treatment of Mood and Anxiety Disorders
    Pittenger, Christopher, Coric, Vladimir, Banasr, Mounira, Bloch, Michael, Krystal, John H, Sanacora, Gerard · 2008 · CNS Drugs
15. Ketamine and Imipramine Reverse Transcriptional Signatures of Susceptibility and Induce Resilience-Specific Gene Expression Profiles
    Rosemary C. Bagot, Hannah M. Cates, Immanuel Purushothaman, Vincent Vialou, Elizabeth A. Heller, Lynn Yieh, Benoît Labonté, Catherine J. Peña, Li Shen, Gayle M. Wittenberg et al. · 2016 · Biological Psychiatry
16. Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine
    Chang, Lijia, Zhang, Kai, Pu, Yaoyu, Qu, Youge, Wang, Si-ming, Xiong, Zhongwei, Ren, Qian, Dong, Chao, Fujita, Yuko, Hashimoto, Kenji · 2019 · Pharmacology Biochemistry and Behavior
17. Prefrontal cortex executive processes affected by stress in health and disease
    Girotti, Milena, Adler, Samantha M., Bulin, Sarah E., Fucich, Elizabeth A., Paredes, Denisse, Morilak, David A. · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
18. Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic
    Peter R Diamond, Andrew D. Farmery, Stephanie A. Atkinson, Jag Haldar, Nicola Williams, Philip J. Cowen, John Richard Geddes, Rupert H. McShane · 2014 · Journal of Psychopharmacology
19. Adjunctive Ketamine With Relapse Prevention–Based Psychological Therapy in the Treatment of Alcohol Use Disorder
    Grabski, Meryem, McAndrew, Amy, Lawn, Will, Marsh, Beth, Raymen, Laura, Stevens, Tobias, Hardy, Lorna, Warren, Fiona, Bloomfield, Michael, Borissova, Anya et al. · 2022 · American Journal of Psychiatry
20. Fast-Acting Antidepressants Rapidly Stimulate ERK Signaling and BDNF Release in Primary Neuronal Cultures
    Lepack, Ashley E., Bang, Eunyoung, Lee, Boyoung, Dwyer, Jason M., Duman, Ronald S. · 2016 · Neuropharmacology
21. Ketamine and other glutamate receptor modulators for depression in adults
    Caddy, Caroline, Amit, Ben H, McCloud, Tayla L, Rendell, Jennifer M, Furukawa, Toshi A, McShane, Rupert, Hawton, Keith, Cipriani, Andrea · 2015 · Cochrane Database of Systematic Reviews
22. The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN
    Fukumoto, Kenichi, Iijima, Michihiko, Chaki, Shigeyuki · 2016 · Neuropsychopharmacology
23. Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration
    Evans, Jennifer W., Szczepanik, Joanna, Brutsché, Nancy, Park, Lawrence T., Nugent, Allison C., Zarate, Carlos A. · 2018 · Biological Psychiatry
24. Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania
    Shaltiel, G, Maeng, S, Malkesman, O, Pearson, B, Schloesser, R J, Tragon, T, Rogawski, M, Gasior, M, Luckenbaugh, D, Chen, G et al. · 2008 · Molecular Psychiatry
25. Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test
    Yang, Chun, Hu, Yi-Min, Zhou, Zhi-Qiang, Zhang, Guang-Fen, Yang, Jian-Jun · 2013 · Upsala Journal of Medical Sciences
26. Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar–Kyoto rats
    Yousef Tizabi, Babur H Bhatti, Kebreten F. Manaye, Jharna R. Das, Luli R. Akinfiresoye · 2012 · Neuroscience
27. Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments
    Elisa Macedo Brietzke, Rodrigo Barbachan Mansur, Mehala Subramaniapillai, Vicent Balanzá‐Martínez, Maj Vinberg, Ana María González-Pinto, Joshua Daniel Rosenblat, Roger Ho, Roger S. McIntyre · 2018 · Neuroscience & Biobehavioral Reviews
28. Ketamine for the treatment of major depression: a systematic review and meta-analysis
    Stevan Nikolin, Anthony Rodgers, Andreas Schwaab, Anees Bahji, Carlos A. Zarate, Gustavo Héctor Vázquez, Colleen K A Loo · 2023 · EClinicalMedicine
29. Ketamine as a Novel Antidepressant: From Synapse to Behavior
    Murrough, J W · 2012 · Clinical Pharmacology & Therapeutics
30. A Single Subanesthetic Dose of Ketamine Relieves Depression-like Behaviors Induced by Neuropathic Pain in Rats
    Jing Wang, Yossef Goffer, Duo Xu, David S. Tukey, Dov B. Shamir, Sarah E. Eberle, Anthony Zou, Thomas J. J. Blanck, Edward Benjamin Ziff · 2011 · Anesthesiology
31. New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs
    Zuleide Maria Ignácio, Gislaine Z. Réus, Camila Orlandi Arent, Helena M. Abelaira, Meagan R. Pitcher, João Quevedo · 2015 · British Journal of Clinical Pharmacology
32. Fighting Females: Neural and Behavioral Consequences of Social Defeat Stress in Female Mice
    Emily L. Newman, Herbert E. Covington, Junghyup Suh, Matthew B. Bicakci, Kerry James Ressler, Joseph F. DeBold, Klaus A. Miczek · 2019 · Biological Psychiatry
33. The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders
    Machado-Vieira, Rodrigo, Manji, Husseini K., Zarate, Carlos A. · 2009 · The Neuroscientist
34. Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
    Cameron, Lindsay P., Benson, Charlie J., Dunlap, Lee E., Olson, David E. · 2018 · ACS Chemical Neuroscience
35. Convergent Mechanisms Underlying Rapid Antidepressant Action
    Zanos, Panos, Thompson, Scott M., Duman, Ronald S., Zarate, Carlos A., Gould, Todd D. · 2018 · CNS Drugs
36. mTOR activation is required for the antidepressant effects of mGluR2/3 blockade
    Dwyer, Jason M., Lepack, Ashley E., Duman, Ronald S. · 2012 · The International Journal of Neuropsychopharmacology
37. Mechanisms of ketamine and its metabolites as antidepressants
    Hess, Evan M., Riggs, Lace M., Michaelides, Michael, Gould, Todd D. · 2022 · Biochemical Pharmacology
38. Psychedelics and Other Psychoplastogens for Treating Mental Illness.
    Vargas, Maxemiliano V., Meyer, Retsina, Avanes, Arabo A., Rus, Mark, Olson, David E. · 2021 · Frontiers in Psychiatry
39. Translating Glutamate: From Pathophysiology to Treatment
    Javitt, Daniel C., Schoepp, Darryle, Kalivas, Peter W., Volkow, Nora D., Zarate, Carlos, Merchant, Kalpana, Bear, Mark F., Umbricht, Daniel, Hajos, Mihaly, Potter, William Z. et al. · 2011 · Science Translational Medicine
40. Rapid Enhancement of Glutamatergic Neurotransmission in Bipolar Depression Following Treatment with Riluzole
    Brennan, Brian P, Hudson, James I, Jensen, J Eric, McCarthy, Julie, Roberts, Jacqueline L, Prescot, Andrew P, Cohen, Bruce M, Pope, Harrison G, Renshaw, Perry F, Öngür, Dost · 2010 · Neuropsychopharmacology
41. Emerging drugs for the treatment of anxiety
    James W. Murrough, Sahab Yaqubi, Sehrish Sayed, Dennis S. Charney · 2015 · Expert Opinion on Emerging Drugs
42. Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial
    Irwin, Scott A., Iglewicz, Alana, Nelesen, Richard A., Lo, Jessica Y., Carr, Connie H., Romero, Sheilani D., Lloyd, Linda S. · 2013 · Journal of Palliative Medicine
43. Association of GRIK4 With Outcome of Antidepressant Treatment in the STAR*D Cohort
    James C. Ballenger · 2009 · Yearbook of Psychiatry and Applied Mental Health
44. Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
    Kadriu, Bashkim, Musazzi, Laura, Henter, Ioline D, Graves, Morgan, Popoli, Maurizio, Zarate, Carlos A · 2019 · International Journal of Neuropsychopharmacology
45. Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
    Niciu, Mark J., Luckenbaugh, David A., Ionescu, Dawn F., Guevara, Sara, Machado-Vieira, Rodrigo, Richards, Erica M., Brutsche, Nancy E., Nolan, Neal M., Zarate, Carlos A. · 2014 · The Journal of Clinical Psychiatry
46. Ketamine for the treatment of addiction: evidence and potential mechanisms
    Ivan Ezquerra-Romano, I., Lawn, W., Krupitsky, E., Morgan, C.J.A. · 2018 · Neuropharmacology
47. Mood disorders: Regulation by metabotropic glutamate receptors
    Pilc, Andrzej, Chaki, Shigeyuki, Nowak, Gabriel, Witkin, Jeffrey M. · 2008 · Biochemical Pharmacology
48. The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors
    Jing Du, Ming Fang Zhu, Hongkun Bao, Li Bai, Yilong Dong, Chunjie Xiao, Grace Y. Zhang, Ioline D. Henter, Matthew V. Rudorfer, Benedetto Vitiello · 2014 · Critical Reviews in Food Science and Nutrition
49. Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine
    Jing Liu, Jacob C. Garza, Jamaur Bronner, Chung Sub Kim, Wei Zhang, Xin‐Yun Lu · 2009 · Psychopharmacology
50. Behavioral and physiological effects of acute ketamine exposure in adult zebrafish
    Russell Riehl, Evan J. Kyzar, Alexander V. Allain, Jeremy B. A. Green, Molly Hook, Louis Monnig, Kate Rhymes, Andrew Roth, Mimi Pham, Roshan Razavi et al. · 2011 · Neurotoxicology and Teratology
51. Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder
    Bloch, Michael H., Wasylink, Suzanne, Landeros-Weisenberger, Angeli, Panza, Kaitlyn E., Billingslea, Eileen, Leckman, James F., Krystal, John H., Bhagwagar, Zubin, Sanacora, Gerard, Pittenger, Christopher · 2012 · Biological Psychiatry
52. Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction
    Pehrson, Alan L., Sanchez, Connie · 2014 · CNS Spectrums
53. Effects of Striatal ΔFosB Overexpression and Ketamine on Social Defeat Stress–Induced Anhedonia in Mice
    Donahue, Rachel J., Muschamp, John W., Russo, Scott J., Nestler, Eric J., Carlezon, William A. · 2014 · Biological Psychiatry
54. Ketamine Treatment for Depression: A Review
    Yavi, Mani, Lee, Holim, Henter, Ioline D., Park, Lawrence T., Zarate, Carlos A. · 2022 · Discover Mental Health
55. Glutamate Receptor Antagonists as Fast-Acting Therapeutic Alternatives for the Treatment of Depression: Ketamine and Other Compounds
    Mark J. Niciu, Ioline D. Henter, David A. Luckenbaugh, Carlos A. Zarate, Dennis S. Charney · 2014 · The Annual Review of Pharmacology and Toxicology
56. Clinically Significant Drug Interactions with Newer Antidepressants
    Edoardo Spina, Gianluca Trifirò, Filippo Caraci · 2011 · CNS Drugs
57. Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight
    Ilina Singh, Celia J. A. Morgan, Valerie H. Curran, David Nutt, Anne Katrin Schlag, Rupert H. McShane · 2017 · The Lancet Psychiatry
58. Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A Preliminary Positron Emission Tomography Study
    Carlson, Paul J., Diazgranados, Nancy, Nugent, Allison C., Ibrahim, Lobna, Luckenbaugh, David A., Brutsche, Nancy, Herscovitch, Peter, Manji, Husseini K., Zarate, Carlos A., Drevets, Wayne C. · 2013 · Biological Psychiatry
59. Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?
    Sanacora, Gerard, Schatzberg, Alan F · 2015 · Neuropsychopharmacology
60. Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: A meta-analysis of randomized clinical trials
    Kryst, Joanna, Kawalec, Paweł, Mitoraj, Alicja Mikrut, Pilc, Andrzej, Lasoń, Władysław, Brzostek, Tomasz · 2020 · Pharmacological Reports
61. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain
    Gislaine Z. Réus, Roberto B. Stringari, Karine F. Ribeiro, Ana K. Ferraro, Marcelo Fontana Vitto, Patrícia A. Cesconetto, Cláudio Teodoro de Souza, João Quevedo · 2011 · Behavioural Brain Research
62. Legal highs: staying on top of the flood of novel psychoactive substances
    David Baumeister, Luis M. Tojo, Derek Kenneth Tracy · 2015 · Therapeutic Advances in Psychopharmacology
63. Antidepressant-relevant concentrations of the ketamine metabolite (2 R ,6 R )-hydroxynorketamine do not block NMDA receptor function
    Lumsden, Eric W., Troppoli, Timothy A., Myers, Scott J., Zanos, Panos, Aracava, Yasco, Kehr, Jan, Lovett, Jacqueline, Kim, Sukhan, Wang, Fu-Hua, Schmidt, Staffan et al. · 2019 · Proceedings of the National Academy of Sciences
64. Neuropathology of suicide: Recent findings and future directions
    Lutz, P-E, Mechawar, N, Turecki, G · 2017 · Molecular Psychiatry
65. The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature
    David Lodge · 2008 · Neuropharmacology
66. Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression
    Licznerski, P., Duman, R.S. · 2013 · Neuroscience
67. A historical review of antidepressant effects of ketamine and its enantiomers
    Yan Wei, Lijia Chang, Kenji Hashimoto · 2020 · Pharmacology Biochemistry and Behavior
68. The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression
    Küçükibrahimoğlu, Esra, Saygın, Melek Z., Çalışkan, Mecit, Kaplan, Okan K., Ünsal, Cüneyt, Gören, M. Zafer · 2009 · European Journal of Clinical Pharmacology
69. Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling
    Cavalleri, L, Merlo Pich, E, Millan, M J, Chiamulera, C, Kunath, T, Spano, P F, Collo, G · 2018 · Molecular Psychiatry
70. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats
    Hiroyuki Koike, Shigeyuki Chaki · 2014 · Behavioural Brain Research
71. Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function
    Ronald S. Duman, Ryota Shinohara, Manoela V. Fogaça, Brendan D. Hare · 2019 · Molecular Psychiatry
72. Learned helplessness: unique features and translational value of a cognitive depression model
    Vollmayr, Barbara, Gass, Peter · 2013 · Cell and Tissue Research
73. Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to an N-Methyl-D-Aspartate Antagonist
    Machado-Vieira, Rodrigo, Yuan, Peixiong, Brutsche, Nancy, DiazGranados, Nancy, Luckenbaugh, David, Manji, Husseini K., Zarate, Carlos A. · 2009 · The Journal of Clinical Psychiatry
74. Cognitive bias in the chick anxiety–depression model
    Amy L. Salmeto, Kristen A. Hymel, Erika C. Carpenter, Ben Brilot, Melissa Bateson B, Kenneth J. Sufka · 2010 · Brain Research
75. Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder
    Mark J. Niciu, Dawn Flosnik Ionescu, Erica M. Richards, Carlos A. Zarate · 2013 · Journal of Neural Transmission
76. ( 2R,6R )-hydroxynorketamine exerts mGlu 2 receptor-dependent antidepressant actions
    Zanos, Panos, Highland, Jaclyn N., Stewart, Brent W., Georgiou, Polymnia, Jenne, Carleigh E., Lovett, Jacqueline, Morris, Patrick J., Thomas, Craig J., Moaddel, Ruin, Zarate, Carlos A. et al. · 2019 · Proceedings of the National Academy of Sciences
77. The effects of low‐dose ketamine on the prefrontal cortex and amygdala in treatment‐resistant depression: A randomized controlled study
    Li, Cheng‐Ta, Chen, Mu‐Hong, Lin, Wei‐Chen, Hong, Chen‐Jee, Yang, Bang‐Hung, Liu, Ren‐Shyan, Tu, Pei‐Chi, Su, Tung‐Ping · 2016 · Human Brain Mapping
78. Blockade of Astrocytic Glutamate Uptake in Rats Induces Signs of Anhedonia and Impaired Spatial Memory
    Anita J. Bechtholt, Hali V Walther, Martha A Adams, William A. Carlezon, Döst Öngür, Bruce M. Cohen · 2010 · Neuropsychopharmacology
79. NMDA Receptor Activity in Neuropsychiatric Disorders
    Shaheen Emmanuel Lakhan, Mario Andres Caro, Norell M. Hadzimichalis · 2013 · Frontiers in Psychiatry
80. Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression
    Romeo, Bruno, Choucha, Walid, Fossati, Philippe, Rotge, Jean-Yves · 2015 · Psychiatry Research
81. A hypothesis of monoamine (5-HT) – Glutamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery
    Yun-Feng Li · 2020 · Pharmacology & Therapeutics
82. Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
    Fortunato, Jucélia J., Réus, Gislaine Z., Kirsch, Tamires R., Stringari, Roberto B., Stertz, Laura, Kapczinski, Flávio, Pinto, Joel P., Hallak, Jaime E., Zuardi, Antônio W., Crippa, José A. et al. · 2009 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
83. Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study
    Carolin Hoyer, Laura Kranaster, Christoph Janke, Alexander Sartorius · 2013 · European Archives of Psychiatry and Clinical Neuroscience
84. Antidepressant actions of ketamine: from molecular mechanisms to clinical practice
    Monteggia, Lisa M, Zarate, Carlos · 2015 · Current Opinion in Neurobiology
85. Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR
    Luli R. Akinfiresoye, Yousef Tizabi · 2013 · Psychopharmacology
86. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder
    Mehdi Ghasemi, Mohammad Kazemi, Abolghasem Yoosefi, Abbas Ghasemi, Pedram Paragomi, Homayoun Amini‎, Mohammad H. Afzali · 2013 · Psychiatry Research
87. Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice
    Juanjuan Tang, Wenda Xue, Baomei Xia, Li Ren, Weiwei Tao, Chang Chen, Hailou Zhang, Ruyan Wu, Qisheng Wang, Haoxin Wu et al. · 2015 · Scientific Reports
88. Pharmacological Treatments for Patients with Treatment-Resistant Depression
    Valerie L. Ruberto, Manish K. Jha, James W. Murrough · 2020 · Pharmaceuticals
89. Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial
    Taylor, Jerome H, Landeros-Weisenberger, Angeli, Coughlin, Catherine, Mulqueen, Jilian, Johnson, Jessica A, Gabriel, Daniel, Reed, Margot O, Jakubovski, Ewgeni, Bloch, Michael H · 2018 · Neuropsychopharmacology
90. Rapid Antidepressant Effect of Ketamine Anesthesia During Electroconvulsive Therapy of Treatment-Resistant Depression
    Nagahisa Okamoto, Tetsuji Nakai, Kota Sakamoto, Yuko Nagafusa, Teruhiko Higuchi, Toru Nishikawa · 2010 · Journal of Ect
91. The role of glutamate on the action of antidepressants
    Kenji Hashimoto · 2010 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
92. New and emerging approaches to treat psychiatric disorders
    Katherine Wilson Scangos, Matthew W. State, Andrew H. Miller, Justin Taylor Baker, Leanne Maree Williams · 2023 · Nature Medicine
93. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
    Hu, Y.-D., Xiang, Y.-T., Fang, J.-X., Zu, S., Sha, S., Shi, H., Ungvari, G. S., Correll, C. U., Chiu, H. F. K., Xue, Y. et al. · 2016 · Psychological Medicine
94. Biological and Psychological Perspectives of Resilience: Is It Possible to Improve Stress Resistance?
    Haoran Liu, Chenfeng Zhang, Yannan Ji, Li Yang · 2018 · Frontiers in Human Neuroscience
95. Neuronal correlates of depression
    Dipesh Chaudhury, He Liu, Ming‐Hu Han · 2015 · Cellular and Molecular Life Sciences
96. A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder
    Milak, M S, Proper, C J, Mulhern, S T, Parter, A L, Kegeles, L S, Ogden, R T, Mao, X, Rodriguez, C I, Oquendo, M A, Suckow, R F et al. · 2016 · Molecular Psychiatry
97. AMPA receptor subunit 1 (GluR‐A) knockout mice model the glutamate hypothesis of depression
    Chourbaji, S., Vogt, M. A., Fumagalli, F., Sohr, R., Frasca, A., Brandwein, C., Hörtnagl, H., Riva, M. A., Sprengel, R., Gass, P. · 2008 · The FASEB Journal
98. Antidepressant actions of ketamine engage cell-specific translation via eIF4E
    Aguilar-Valles, Argel, De Gregorio, Danilo, Matta-Camacho, Edna, Eslamizade, Mohammad J., Khlaifia, Abdessattar, Skaleka, Agnieszka, Lopez-Canul, Martha, Torres-Berrio, Angelica, Bermudez, Sara, Rurak, Gareth M. et al. · 2021 · Nature
99. Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression
    Beata Karolewicz, Katalin Szebeni, Tempestt Gilmore, Dorota Maciąg, Craig A. Stockmeier, Gregory A. Ordway · 2008 · The International Journal of Neuropsychopharmacology
100. Is subcortical–cortical midline activity in depression mediated by glutamate and GABA? A cross-species translational approach
     Alcaro, Antonio, Panksepp, Jaak, Witczak, Jan, Hayes, Dave J., Northoff, Georg · 2010 · Neuroscience & Biobehavioral Reviews